Neuroprotection in acute brain injury: an up-to-date review
Affiliation
Department of Physiopathology and Transplant, Milan UniversityNeuro ICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles
Department of Health Science, University of Milan-Bicocca, Ospedale San Gerardo
NeuroIntensive Care, Department of Emergency and Intensive Care, Ospedale San Gerardo
Department of Emergency Medicine, University of Texas Southwestern Medical Center at Dallas
Department of Neurosurgery, Lankenau Medical Center
Department of Intensive Care Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) University Hospital, Faculty of Biology and Medicine, University of Lausanne
Department of Critical Care Medicine, University of Pittsburgh Medical Center
Division of Neuroscience Critical Care, Division of Adult Critical Care, Johns Hopkins MedicineNETT Clinical Coordinating Center, University of MichiganDepartment of Neurosurgery, University Hospital Antwerp and University of AntwerpDepartment of Intensive Care, UZ Leuven, Campus GasthuisbergDepartment of Critical Care Medicine and the Safar Center for Resuscitation Research, University of Pittsburgh Medical CenterDepartment of Neurocritical Care, David Geffen School of Medicine at UCLACenter for Shock, Trauma & Anesthesiology Research (STAR), University of Maryland School of MedicineDepartment of Neurology, Neurocritical Care Unit, Innsbruck Medical UniversityDepartment of Surgery, R Adams Cowley Shock Trauma Center, University of Maryland School of MedicineIRCCS – Istituto di Ricerche Farmacologiche Mario Negri, Department of NeuroscienceDepartment of Emergency Medicine, University of ArizonaInstitute of Liver Studies, King’s College HospitalDivision of Anaesthesia, University of Cambridge, Addenbrooke’s Hospital
Issue Date
2015Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Stocchetti et al. Critical Care (2015) 19:186 DOI 10.1186/s13054-015-0887-8Journal
Critical CareRights
© 2015 Stocchetti et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0).Collection Information
This item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.Abstract
Neuroprotective strategies that limit secondary tissue loss and/or improve functional outcomes have been identified in multiple animal models of ischemic, hemorrhagic, traumatic and nontraumatic cerebral lesions. However, use of these potential interventions in human randomized controlled studies has generally given disappointing results. In this paper, we summarize the current status in terms of neuroprotective strategies, both in the immediate and later stages of acute brain injury in adults. We also review potential new strategies and highlight areas for future research.EISSN
1466-609XVersion
Final published versionAdditional Links
http://www.ccforum.com/content/19/1/186Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2015 Stocchetti et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0).